Metraipolis › archive › dc_6ef8d819ef9f
Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives — Europe PMC PMID:42198250
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42198250
- DOI
- 10.3390/pharmaceutics18050557
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T00:26:50.047Z
- SHA-256 of the archived text
c84cf5195001981cc88f7d4d66ff2811a98931219c8dd64d1d59b8d02dcff915- Stable URL of this page
https://metraipolis.com/documento/dc_6ef8d819ef9f
How to cite
Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives — Europe PMC PMID:42198250 — Europe PMC (en), https://europepmc.org/article/MED/42198250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ef8d819ef9f (Metraipolis archive dc_6ef8d819ef9f, sha256 c84cf5195001981cc88f7d4d66ff2811a98931219c8dd64d1d59b8d02dcff915)
BibTeX
@misc{dc6ef8d819ef9f,
title = {Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives — Europe PMC PMID:42198250},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42198250},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ef8d819ef9f; sha256 c84cf5195001981cc88f7d4d66ff2811a98931219c8dd64d1d59b8d02dcff915},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198250. Agents can read the archived copy with the MCP tool read_document.